Pro Dex Inc (PDEX) financials

NASDAQ · Health Care

$58.16 -5.58% Close Oct 30, 2026 Live

Pro Dex revenue and earnings by year

Pro Dex's revenue was $77.5 million in the fiscal year to June 30, 2026, up 16.5% from the year before. Net income was $13.7 million, 17.6% of revenue. Since the fiscal year to June 30, 2017, revenue has grown 15.1% a year on average.

RevenueNet income
$25.0M$50.0M$75.0M
2017201820192020202120222023202420252026

Fiscal years, each labelled by the calendar year it ended in.

Income statement, the last 10 fiscal years

In millions of US dollars except per-share figures. Each column is a fiscal year, named by the month it ended.
Fiscal year toJun 2026Jun 2025Jun 2024Jun 2023Jun 2022Jun 2021Jun 2020Jun 2019Jun 2018Jun 2017
Revenue78675446423835272222
Revenue growth16.5%23.7%16.8%9.6%10.5%9.2%28.2%21.0%2.4%—
Gross profit242015131314131087
Gross margin31.4%29.3%27.0%27.7%31.2%35.7%37.7%36.0%35.4%32.7%
Operating income131176557523
Operating margin16.8%16.1%13.3%12.5%12.2%11.9%20.3%18.4%10.6%12.5%
Net income14927566425
Net margin17.6%13.5%4.0%15.3%10.9%16.2%17.5%15.3%7.2%23.2%
Diluted EPS$4.12$2.67$0.60$1.95$1.22$1.55$1.50$0.97$0.37$1.25
Free cash flow7-354-2-104223

Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open PDEX in Markets.

See also: PDEX valuation and P/E history · PDEX returns

No forecast, no recommendation. This page describes Pro Dex Inc from published data; it is not advice to buy, sell or hold any security.

Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.